Nuclear damage in LMNA mutant iPSC-derived cardiomyocytes is associated with impaired lamin localization to the nuclear envelope

Melanie Wallace, Hind Zahr, Shriya Perati, Chloé D. Morsink, Lindsey E. Johnson, Anthony M. Gacita, Shuping Lai, Lori L. Wallrath, Ivor J. Benjamin, Elizabeth M. McNally, Tyler J. Kirby, Jan Lammerding*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

The LMNA gene encodes the nuclear envelope proteins Lamins A and C, which comprise a major part of the nuclear lamina, provide mechanical support to the nucleus, and participate in diverse-intracellular signaling. LMNA mutations give rise to a collection of diseases called laminopathies, including dilated cardiomyopathy (LMNA-DCM) and muscular dystrophies. Although nuclear deformities are a hallmark of LMNA-DCM, the role of nuclear abnormalities in the pathogenesis of -DCM remains incompletely understood. Using induced-pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) from LMNA-mutant patients and healthy controls, we show that LMNA mutant iPSC-CM nuclei have altered shape or increased size compared with healthy control iPSC-CM nuclei. The LMNA mutation exhibiting the most severe nuclear deformities, R249Q, additionally caused reduced nuclear stiffness and increased nuclear fragility. Importantly, for all cell lines, the degree of nuclear abnormalities corresponded to the degree of Lamin A/C and Lamin B1 mislocalization from the nuclear envelope. The mislocalization was likely due to altered assembly of Lamin A/C. Collectively, these results point to the importance of correct lamin assembly at the nuclear envelope in providing mechanical stability to the nucleus and suggests that defects in nuclear lamina organization may contribute to the nuclear and cellular dysfunction in LMNA-DCM.

Original languageEnglish (US)
JournalMolecular biology of the cell
Volume34
Issue number12
DOIs
StatePublished - Nov 10 2023

Funding

The authors thank the Cure Muscular Dystrophy Foundation for the LMNA L35P iPSCs; Hanna Gimse for analyzing the nuclear volume in shRNA experiments; the Cornell Institute of Biotechnology for performing library preparation and Illumina sequencing experiments; the Cornell Statistical Consulting Unit for developing the regressions performed in R; Dr. Kehan Zhang and Dr. Christopher Chen for hosting M.W. to learn iPSC culture and cardiac differentiation protocols; and Dr. Kathleen Xie for the nuclear semipermeabilization protocol. This work was supported by awards from the National Institutes of Health (R01 HL082792 to J.L., R01 HL128075 to E.M.M., and F30 HL142187 to A.M.G.); the National Science Foundation (CBET 1715606 and URoL-2022048 to J.L.; Graduate Research Fellowships 2016229710 to M.W.), the American Heart Association (20PRE35080179 to M.W.), the Muscular Dystrophy Association (MDA603238 to T.J.K), and the Volkswagen Foundation (A130142 to J.L.).

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Fingerprint

Dive into the research topics of 'Nuclear damage in LMNA mutant iPSC-derived cardiomyocytes is associated with impaired lamin localization to the nuclear envelope'. Together they form a unique fingerprint.

Cite this